Tech Company Financing Transactions
GangaGen Funding Round
GangaGen, based in Palo Alto, scored $5.4 million from Atel Ventures and private investors.
Transaction Overview
Company Name
Announced On
11/24/2008
Transaction Type
Venture Equity
Amount
$5,400,000
Round
Series E
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3279 Emerson
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Overview
GangaGen, Inc. is a biotechnology company focused on the development of proprietary, bacteriophage-based products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Shashimohan Keelara
President
T.S. Balganesh
President
Amy Percy
VP - Bus. Development
Sukumar Hariharan
VP - R & D
Umender Sharma
VP - R & D
Bharathi Sriram
Browse more venture capital transactions:
Prev: 11/24/2008: kajeet venture capital transaction
Next: 11/24/2008: FanSnap venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs